<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01805674</url>
  </required_header>
  <id_info>
    <org_study_id>ESTROCALVI</org_study_id>
    <nct_id>NCT01805674</nct_id>
  </id_info>
  <brief_title>Isoflavones and Magnolia Extract in the Quality of Life in Menopausal Women</brief_title>
  <acronym>ESTROCALVI</acronym>
  <official_title>Study to Evaluate the Changes in Quality of Life in Menopausal Women After the Administration of Soy Isoflavones Combined With Magnolia Extract</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rottapharm Spain</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rottapharm Spain</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In menopause, the vasomotor symptomatology, accompanied or less by affective and behavioural
      symptoms, globally worsens the quality of daily life.

      The improvement of the quality could be reached with adequate food supplements, named
      phytoestrogens, in particular Soy Isoflavones (SI), which are natural substances with
      estrogen-like and estrogen-antagonistic activity, which are active in the control of
      menopausal vasomotor symptoms. Besides, combined with magnolia extract it could improve the
      psychological symptomatology also improving the quality of life.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Multicenter, observational, prospective, longitudinal study of clinical practice conducted in
      10 gynecological centers.

      The study will be conducted in patients with typical mild to moderate vasomotor symptoms and
      psycho symptoms such as mood disorders, or sleep, anxiety / depression, which do not require
      specific drug treatment.

      Quality of life will be analyzed by the scale of Cervantes.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Actual">October 2013</completion_date>
  <primary_completion_date type="Actual">July 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>the quality of life measured by the scale of Cervantes</measure>
    <time_frame>baseline and 12 weeks</time_frame>
    <description>The Cervantes scale is a Spanish validated questionnaire specific for measure the quality of life in menopausal women</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical changes in vasomotor symptomatology</measure>
    <time_frame>baseline, 2, 4, 8 and 12 weeks</time_frame>
    <description>In a semiquantitative scale of intensity the vasomotor, psychological and sexual symptomatology will be evaluated in each visit</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">100</enrollment>
  <condition>Menopause</condition>
  <arm_group>
    <arm_group_label>isoflavones combined with magnolia</arm_group_label>
    <description>A food supplement containing soy isoflavones, lactobacillus sporogenous, Ca,vitamin D3, magnesium and magnolia extract will be administered once a day during 12 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>isoflavones combined with magnolia</intervention_name>
    <description>1 tablet/day duration: 12 weeks</description>
    <arm_group_label>isoflavones combined with magnolia</arm_group_label>
    <other_name>Estromineral Serena</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study will be conducted in patients with typical mild to mderate vasomotor symptoms and
        psycho symptoms such as mood changes, or sleep, anxiety / depression, which do not require
        specific drug treatment.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women with at least 12 months of amenorrhea

          -  Presence of 1 or more vasomotor symptoms as hot flushing, nocturnal sweating or
             palpitations

          -  One or more psychological symptoms as insomnia, irritability, anxiety, depressed mood.
             Also with concomitant symptoms of sexual area as reduction of libido and vaginal
             dryness.

          -  Women must give the informed consent

        Exclusion Criteria:

          -  clinical history of medical or surgical pathologies that could affect the results of
             the study, including serious cardiovascular, metabolic, kidney or liver diseases

          -  Patients with the habit of eating soy foods or dietary supplements with soy extract

          -  patients diagnosed with breast or uterine mass (neoplasia hormone sensitive)

          -  patients that were treated with estrogens (HRT or phytoestrogens)in the 2 months
             before the beginning of the study.

          -  patients with treatment with antibiotics, antidepressant and/or anxiolytic products
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>59 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anna Anguera, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Rottapharm S.L.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rafael Sánchez-Borrego, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centro Médico Teknon</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Grupo hospitalario Quirón</name>
      <address>
        <city>Erandio</city>
        <state>Vizcaya</state>
        <zip>48950</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Somdex S.L.</name>
      <address>
        <city>Barcelona</city>
        <zip>08017</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro Médico Teknon</name>
      <address>
        <city>Barcelona</city>
        <zip>08022</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Surgery of Dr. Sánchez Muñoz</name>
      <address>
        <city>Ciudad Real</city>
        <zip>13004</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gabinete Médico Velazquez</name>
      <address>
        <city>Madrid</city>
        <zip>28001</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clínica ginecológica Cecchini</name>
      <address>
        <city>Oviedo</city>
        <zip>33004</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Instituto Sevillano de Ginecología y Obstetricia</name>
      <address>
        <city>Sevilla</city>
        <zip>41003</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Surgery of Dr. Mahiques</name>
      <address>
        <city>Valencia</city>
        <zip>46006</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Surgery of Dr. Raga</name>
      <address>
        <city>Valencia</city>
        <zip>46006</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro Ginecológico Dr. García Pérez-Llantada SL</name>
      <address>
        <city>Zaragoza</city>
        <zip>50008</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>November 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 1, 2013</study_first_submitted>
  <study_first_submitted_qc>March 5, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 6, 2013</study_first_posted>
  <last_update_submitted>November 4, 2014</last_update_submitted>
  <last_update_submitted_qc>November 4, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 5, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>menopause</keyword>
  <keyword>quality of life</keyword>
  <keyword>soy isoflavones</keyword>
  <keyword>magnolia extract</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

